About This Episode
Free for BOA listeners: Book a complimentary 60-minute marketing strategy session with Ekwa → https://www.businessofaesthetics.org/msm/
In this episode, host Don welcomes Dr. Rob Knight, Vice President of Research and Clinical Development at Cellese and AnteAGE, to examine one of the most overlooked profit leaks in aesthetics: what happens after a clinically perfect treatment. Dr. Knight, who holds a PhD in Stem Cell and Extracellular Vesicle Biology, explains why practices control every variable in the treatment room yet lose control the moment the patient goes home, and how unclear or underwhelming recovery can quietly end the relationship.
Dr. Knight breaks down how to build a recovery protocol around real skin biology: managing inflammation and oxidative stress, protecting the barrier and hydration, and engineering the first seven days from chairside application to sustained home care. He also shares a practical evidence ladder for vetting regenerative products such as exosomes and PDRN, from source and manufacturing to finished-product testing and clinical data with objective and patient-reported endpoints, and explains why topical-only use matters.
His closing message: sell the full treatment plan up front, control the home care between visits, and measure plan adherence rather than chasing re-bookings one visit at a time. The episode also features Naren Arulrajah's marketing tip on what to check when new patient counts drop: keyword visibility, Google reviews, and phone conversion.